🌟 Pharmidex is proud to sponsor CamMedChem’25! 🌟
September 12, 2025
We’re delighted to announce that
Pharmidex will be an official sponsor of
CamMedChem’25, the renowned meeting organized by the Royal Society of Chemistry’s Biomolecular Chemistry Special Interest Group
This year’s theme promises cutting-edge discussions in medicinal chemistry, biomolecular interactions and the latest trends in small molecule and chemical biology research.
We’re honoured to support such a pivotal forum for scientists, drug discovery experts and academic innovators to exchange ideas, foster collaborations, and advance therapeutic discovery.
👉 We look forward to:
Learning from the powerful scientific insights shared at the meeting
Exploring new partnerships that further the translation of biomolecular science into impactful therapies
We can’t wait to see you in Cambridge for CamMedChem’25!
#CamMedChem25 #MedicinalChemistry #DrugDiscovery #Pharmidex #BMCS
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
